Nov 13, 2020 / 06:15PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Okay. Good afternoon, everybody. We're just going to wait 2, 3 seconds, make sure everything is clicking in. And so good afternoon, everybody, and thank you for joining us for the Fourth Annual IO Summit that annually coincides with the Citi Conference. I'm Yaron Werber, biotech analyst here at Cowen, and it's a great pleasure to moderate the session today with Regeneron. The team here really needs no introduction.
We have with us today, Izzy Lowy, who is the Senior Vice President for Translational Sciences and Oncology; and also Andres Sirulnik, who is the Senior Vice President for Translational and Clinical Sciences, Hematology, and everybody, of course, knows Justin Holko, VP of IR.
So we're going to pass it on to Justin to give the quick forward-looking statements, then Izzy is going to make some opening remarks. If you want to ask any questions, just look below the webcast window. There's a little box there, you can kind of punch in your question, and we'll be happy to read it
Regeneron Pharmaceuticals Inc at Cowen Immuno-Oncology Next Summit Transcript
Nov 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers